12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga · 05/01 17:06
Gainers
- TransCode Therapeutics (NASDAQ:RNAZ) stock rose 80.5% to $0.73 during Thursday's regular session. The market value of their outstanding shares is at $17.1 million.
- Healthcare Triangle (NASDAQ:HCTI) stock moved upwards by 79.87% to $0.28. The company's market cap stands at $12.7 million.
- NanoVibronix (NASDAQ:NAOV) shares increased by 30.44% to $3.73. The company's market cap stands at $3.0 million.
- Pheton Holdings (NASDAQ:PTHL) shares moved upwards by 29.48% to $4.04. The company's market cap stands at $58.5 million.
- LogicMark (NASDAQ:LGMK) shares increased by 26.43% to $0.02.
- HOOKIPA Pharma (NASDAQ:HOOK) shares increased by 22.1% to $1.16. The company's market cap stands at $13.9 million.
Losers
- Organon (NYSE:OGN) stock fell 27.2% to $9.41 during Thursday's regular session. The market value of their outstanding shares is at $2.4 billion. As per the press release, Q1 earnings came out today.
- Arvinas (NASDAQ:ARVN) stock declined by 24.23% to $7.29. The market value of their outstanding shares is at $501.3 million. As per the press release, Q1 earnings came out today.
- Kronos Bio (NASDAQ:KRON) stock declined by 22.75% to $0.69. The market value of their outstanding shares is at $42.0 million.
- Phathom Pharmaceuticals (NASDAQ:PHAT) stock decreased by 22.5% to $3.33. The company's market cap stands at $231.5 million. As per the press release, Q1 earnings came out today.
- Pulmonx (NASDAQ:LUNG) shares decreased by 18.43% to $3.94. The company's market cap stands at $156.7 million. As per the press release, Q1 earnings came out yesterday.
- INVO Fertility (NASDAQ:IVF) shares fell 18.42% to $1.95. The market value of their outstanding shares is at $9.6 million. As per the news, the Q4 earnings report came out 3 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.